{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:34:33Z","timestamp":1773059673867,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Treatment resistance in schizophrenia is associated with both intellectual disability and rare genetic variation. Information pertaining to the use of clozapine in this context has primarily come from case reports and small case series. Given the frequent occurrence of comorbid medical issues in various genetic disorders and the heightened sensitivity to antipsychotic medications among intellectually disabled individuals, additional information regarding the effectiveness and tolerability of clozapine in this population is needed, particularly in light of its unique side effect profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective review of 1200 charts, which took place at a subspecialty psychiatry clinic, sought to characterize the use of clozapine in individuals with schizophrenia (or psychotic symptoms, generally speaking) and intellectual disability occurring on the background of rare genetic variation, a difficult to study and underserved patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twelve hundred charts were reviewed and 10 eligible individuals were identified, all of whom had been prescribed clozapine and carried a diagnosis of schizophrenia on the background of intellectual disability and rare genetic variation. Six of these 10 individuals harbored presumed pathogenic variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications:<\/jats:title>\n                    <jats:p>\n                      This study affirms what is known about clozapine treatment in 22q11.2 deletion syndrome, adds to the scarce literature on Usher syndrome in this context, and provides the first accounts of clozapine use in 22q11.2 microduplication syndrome and\n                      <jats:italic toggle=\"yes\">DCX<\/jats:italic>\n                      variant-related heterotopia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/jcp.0000000000002000","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T16:02:31Z","timestamp":1743782551000},"page":"329-335","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8151-1173","authenticated-orcid":false,"given":"Mark A.","family":"Colijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"R1-20260219","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.3725","article-title":"Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects","volume":"49","author":"Marshall","year":"2017","journal-title":"Nat Genet"},{"key":"R2-20260219","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"key":"R3-20260219","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ng.3903","article-title":"The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability","volume":"49","author":"Singh","year":"2017","journal-title":"Nat Genet"},{"key":"R4-20260219","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18com12123","article-title":"Clinical guidance on the identification and management of treatment-resistant schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"R5-20260219","first-page":"CD010625","article-title":"Clozapine for psychotic disorders in adults with intellectual disabilities","volume":"2015","author":"Ayub","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20260219","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112560118","article-title":"High-impact rare genetic variants in severe schizophrenia","volume":"118","author":"Zoghbi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-20260219","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/schbul\/sbac175","article-title":"Increased prevalence of rare copy number variants in treatment-resistant psychosis","volume":"49","author":"Farrell","year":"2023","journal-title":"Schizophr Bull"},{"key":"R8-20260219","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5582\/irdr.2015.01028","article-title":"Psychosis and catatonia in fragile X: case report and literature review","volume":"4","author":"Winarni","year":"2015","journal-title":"Intractable Rare Dis Res"},{"key":"R9-20260219","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmg.2016.08.003","article-title":"Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor","volume":"59","author":"Breckpot","year":"2016","journal-title":"Eur J Med Genet"},{"key":"R10-20260219","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/WNF.0000000000000226","article-title":"Sleep disturbance as a precursor of severe regression in Kleefstra syndrome suggests a need for firm and rapid pharmacological treatment","volume":"40","author":"Vermeulen","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"R11-20260219","first-page":"380","article-title":"C.4168G\u2009>\u2009A(p.Ala 1390Thr) variation in KMT2D gene detected in an ultra-treatment-resistant schizophrenia patient: a case report and literature review","volume":"60","author":"Alp","year":"2023","journal-title":"Noro Psikiyatr Ars"},{"key":"R12-20260219","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/PRA.0000000000000685","article-title":"Mutation of GPR143 associated with ocular albinism type 1, intellectual disability, and schizophrenia: the complex biological and social interactions between genetic syndromes and mental illness","volume":"29","author":"Arcadepani","year":"2023","journal-title":"J Psychiatr Pract"},{"key":"R13-20260219","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12888-023-04962-y","article-title":"Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R14-20260219","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000531747","article-title":"Response to treatment in 3q29 deletion syndrome-associated psychosis: a mini-review","volume":"82","author":"Colijn","year":"2023","journal-title":"Neuropsychobiology"},{"key":"R15-20260219","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JCP.0000000000001816","article-title":"Clozapine use in 22q11.2 deletion syndrome: a systematic review of the literature","volume":"44","author":"Colijn","year":"2024","journal-title":"J Clin Psychopharmacol"},{"key":"R16-20260219","first-page":"1","article-title":"Phelan-McDermid syndrome-associated psychosis: a systematic review","volume":"1\u201325","author":"Colijn","year":"2024","journal-title":"Acta Neuropsychiatr"},{"key":"R17-20260219","doi-asserted-by":"crossref","first-page":"110888","DOI":"10.1016\/j.pnpbp.2023.110888","article-title":"SETD1A variant-associated psychosis: a systematic review of the clinical literature and description of two new cases","volume":"129","author":"Colijn","year":"2024","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R18-20260219","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/13554794.2022.2132869","article-title":"A 1p31.3 deletion encompassing the nuclear factor 1A gene presenting as possible temporal lobe epilepsy in association with schizoaffective disorder","volume":"28","author":"Colijn","year":"2022","journal-title":"Neurocase"},{"key":"R19-20260219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YPG.0000000000000354","article-title":"Maternal 15q11.2-q13.1 duplication syndrome-associated psychosis and mania: a new case and review of the literature","volume":"34","author":"Colijn","year":"2024","journal-title":"Psychiatr Genet"},{"key":"R20-20260219","doi-asserted-by":"crossref","first-page":"e017406","DOI":"10.1136\/bmjopen-2017-017406","article-title":"Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study","volume":"7","author":"Sheehan","year":"2017","journal-title":"BMJ Open"},{"key":"R21-20260219","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajmg.a.62577","article-title":"22q11.2 duplications: expanding the clinical presentation","volume":"188","author":"Bartik","year":"2022","journal-title":"Am J Med Genet A"},{"key":"R22-20260219","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamapsychiatry.2016.1831","article-title":"Analysis of intellectual disability copy number variants for association with schizophrenia","volume":"73","author":"Rees","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R23-20260219","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/07067437241293983","article-title":"Real-world treatment of schizophrenia in adults with a 22q11.2 microdeletion: Traitement dans le monde reel de la schizophrenie chez des adultes atteints du syndrome de microdeletion 22q11.2","volume":"70","author":"Van","year":"2024","journal-title":"Can J Psychiatry"},{"key":"R24-20260219","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/YIC.0000000000000513","article-title":"Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series","volume":"39","author":"Berardelli","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"R25-20260219","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00787-019-01326-4","article-title":"Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review","volume":"29","author":"Mosheva","year":"2020","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R26-20260219","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1192\/bjp.bp.114.151837","article-title":"Response to clozapine in a clinically identifiable subtype of schizophrenia","volume":"206","author":"Butcher","year":"2015","journal-title":"Br J Psychiatry"},{"key":"R27-20260219","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","article-title":"Seizure associated with clozapine: incidence, etiology, and management","volume":"29","author":"Williams","year":"2015","journal-title":"CNS Drugs"},{"key":"R28-20260219","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s10072-021-05825-8","article-title":"Neurological manifestation of 22q11.2 deletion syndrome","volume":"43","author":"Bayat","year":"2022","journal-title":"Neurol Sci"},{"key":"R29-20260219","doi-asserted-by":"crossref","first-page":"108520","DOI":"10.1016\/j.yebeh.2021.108520","article-title":"Epilepsy in patients with schizophrenia: pathophysiology and basic treatments","volume":"127","author":"Adachi","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"Pt 5","key":"R30-20260219","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2788.2000.00270.x","article-title":"Epilepsy and intellectual disability","volume":"44","author":"Bowley","year":"2000","journal-title":"J Intellect Disabil Res"},{"key":"R31-20260219","first-page":"2515841420952194","article-title":"Usher syndrome: clinical features, molecular genetics and advancing therapeutics","volume":"12","author":"Toms","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"key":"R32-20260219","first-page":"1","article-title":"Current updates on genetic spectrum of usher syndrome","volume":"1\u201324","author":"Ullah","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"R33-20260219","first-page":"50","article-title":"Psychosis, mood and behavioral disorders in usher syndrome: review of the literature","volume":"4","author":"Domanico","year":"2015","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R34-20260219","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.psychres.2017.01.102","article-title":"Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders","volume":"252","author":"McCarthy-Jones","year":"2017","journal-title":"Psychiatry Res"},{"key":"R35-20260219","first-page":"68","article-title":"Usher syndrome and psychiatric symptoms: a challenge in psychiatric management","volume":"21","author":"Rijavec","year":"2009","journal-title":"Psychiatr Danub"},{"key":"R36-20260219","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/aip.aip_36_24","article-title":"Chronic psychosis in a patient with usher syndrome","volume":"9","author":"Bhat","year":"2024","journal-title":"Ann Indian Psychiatry"},{"key":"R37-20260219","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmg.2018.01.003","article-title":"PDD-NOS, psychotic features and executive function deficits in a boy with proximal 22q11.2 microduplication: evolution of the psychiatric symptom profile from childhood to adolescence","volume":"61","author":"Woestelandt","year":"2018","journal-title":"Eur J Med Genet"},{"key":"R38-20260219","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2015.12.019","article-title":"Psychotic disorder associated with 22q11.2 duplication syndrome","volume":"236","author":"Amelsvoort","year":"2016","journal-title":"Psychiatry Res"},{"key":"R39-20260219","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/378818","article-title":"Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients","volume":"73","author":"Ensenauer","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R40-20260219","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105505","article-title":"Phenotypic variability in novel Doublecortin gene variants associated with subcortical band heterotopia","volume":"25","author":"Procopio","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R41-20260219","doi-asserted-by":"crossref","first-page":"116052","DOI":"10.1016\/j.psychres.2024.116052","article-title":"Genetic testing in individuals experiencing psychosis: a practical guide for psychiatrists","volume":"339","author":"Colijn","year":"2024","journal-title":"Psychiatry Res"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000002000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:00:43Z","timestamp":1771513243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000002000"}},"subtitle":["A Retrospective Chart Review"],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000002000","relation":{},"ISSN":["1533-712X","0271-0749"],"issn-type":[{"value":"1533-712X","type":"electronic"},{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}